Skip to main content

Table 1 Baseline characteristics and outcomes

From: Association between delay in intensive care unit admission and the host response in patients with community-acquired pneumonia

 

Direct ICU admission

Delayed ICU admission

P value

Patients

387

143

 

Demographics

 Age, years, median [IQR]

62 [49, 72]

64 [51, 73]

.47

 Gender male, n (%)

252 (65.1)

83 (58.0)

.26

 White race, n (%)

344 (88.9)

123 (86.0)

.45

 Readmissiona, n (%)

11 (2.8)

3 (2.1)

.87

Chronic comorbidity, n (%)

 None

110 (28.4)

35 (24.5)

.43

 Immunocompromised state

82 (21.2)

50 (35.0)

.002

 Cardiovascular insufficiency

110 (28.4)

32 (22.4)

.20

 Malignancy

52 (13.4)

33 (23.1)

.011

 Renal insufficiency

41 (10.6)

19 (13.3)

.48

 Respiratory insufficiency

114 (29.5)

35 (24.5)

.31

 COPD

82 (21.2)

26 (18.2)

.52

 Diabetes mellitus

86 (22.2)

24 (16.8)

.21

 Charlson comorbidity index

4 [2, 6]

4 [3, 6]

.18

Vital signs on admission, median [IQR]

 Temperature

38 [37, 38]

38 [37, 39]

.14

 PaO2/FiO2 ratio

114 [57, 477]

102 [50, 351]

.21

 PEEP during first 24 h, cm H2O

24 [7, 25]

24 [6, 24]

.47

Severity of disease on ICU admission

 APACHE IV Score, median [IQR]

75 [59, 98]

75 [60, 92]

.75

 SOFA total, median [IQR]

6 [4, 8]

6 [4, 8]

.69

 Mechanical ventilation, n (%)

303 (78.3)

101 (70.6)

.08

 Shock, n (%)

179 (46.6)

48 (33.6)

.010

 Acute kidney injury, n (%)

121 (31.3)

36 (25.2)

.21

 Acute respiratory distress syndrome, n (%)

95 (24.5)

36 (25.2)

.97

 Acute myocardial infarction, n (%)

14 (3.6)

3 (2.1)

.55

Causative pathogens

  

.08

 Gram-positive bacteria

68 (17.6)

17 (11.9)

 

 Gram-negative bacteria

57 (14.7)

24 (16.8)

 

 Atypical bacteria

1 (0.3)

1 (0.7)

 

 Virus

16 (4.1)

12 (8.4)

 

 Fungi

11 (2.8)

10 (7.0)

 

 Other pathogens

1 (0.3)

1 (0.7)

 

 Multiple pathogens

42 (10.9)

11 (7.7)

 

 Unknown

191 (49.4)

67 (46.9)

 

Outcome

 Length of ICU stay, days, median [IQR]

5 [3, 9]

5 [2, 9]

.79

 Length of hospital stay, days, median [IQR]

12 [16, 24]

14 [7, 24]

.21

MV characteristics

 Duration of initial MV, days, median [IQR]

2 [1, 6]

2 [1, 6]

.34

 Recurrence of MV, n (%)

10 (2.6)

10 (7.0)

.035

 MV-free daysb, median [IQR]

22 [5, 26]

21 [5, 25]

.39

ICU-acquired complications, n (%)

 None

327 (84.5)

122 (85.3)

.92

 Acute kidney injury

35 (9.0)

11 (7.7)

.75

 Acute respiratory distress syndrome

22 (5.7)

7 (4.9)

.89

 Infection

25 (6.5)

11 (7.7)

.76

Mortalityc, n (%)

 ICU

71 (18.9)

27 (19.3)

 > .99

 Hospital

101 (26.9)

46 (32.9)

.22

 30 days

107 (28.5)

44 (31.4)

.58

 60 days

123 (32.7)

53 (37.9)

.32

 90 days

129 (34.3)

61 (43.6)

.07

 1 year

158 (42.0)

71 (50.7)

.10

  1. APACHE Acute Physiology and Chronic Health Evaluation, COPD chronic obstructive pulmonary disease, ED emergency department, FiO2 fraction of inspired oxygen, ICU intensive care unit, IQR interquartile range, MV mechanical ventilation, PaO2 partial pressure of oxygen in arterial blood gas analysis, PEEP positive end-expiratory pressure, SOFA Sequential Organ Failure Assessment
  2. aReadmissions > 30 days after hospital discharge
  3. bDays alive and free from MV on day 28 of ICU stay
  4. cMortality was calculated using the first ICU-admission for each patient; readmissions were not included in this analysis